Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
fda
3
×
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
3
×
raleigh-durham top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
alprazolam
amgen
anaphylaxis
andrew oxtoby
arena pharmaceuticals
cancer
cardiovascular disease
cgrp inhibitors
chronic migraine
colorectal cancer
What
drug
3
×
fda
approval
friday
won
acute
addresses
agency
aimmune
allergy
approved
awarded
cancer
causes
condition
decades
developed
eisai
eli
flags
giant
giving
higher
immunotherapy
incidence
lasmiditan
late
lilly
lilly’s
lorcaserin
loss
market
marketing
medication
medicine
migraine
new
oks
oral
patients
Language
unset
3
×
Current search:
drug
×
unset
×
" raleigh-durham blog main "
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades